SML2607

Clevidipine Butyrate

≥98% (HPLC)

• Synonym(s): 4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid 3-methyl 5-[(1-oxobutoxy)methyl] ester, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl- 3,5-pyridinedicarboxylic acid methyl (1-oxobutoxy)methyl ester, H 324/38
• Empirical Formula (Hill Notation): C₂₁H₂₃Cl₂NO₆
• CAS Number: 167221-71-8
• Molecular Weight: 456.32
• MDL number: MFCD00940070
• UNSPSC Code: 12352200
• NACRES: NA.77

Properties

• Assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: 2-8°C
• InChI: 1S/C21H23Cl2NO6/c1-5-7-15(25)29-10-30-21(27)17-12(3)24-11(2)16(20(26)28-4)18(17)13-8-6-9-14(22)19(13)23/h6,8-9,18,24H,5,7,10H2,1-4H3
• InChI key: KPBZROQVTHLCDU-UHFFFAOYSA-N

Description

Biochem/physiol Actions

Clevidipine is a short acting, third generation dihydropyridine calcium channel blocker that is highly selective for vascular L-type calcium channels. Clevidipine has no effect on myocardial contractility or cardiac conduction.

Safety Information

• Pictograms: GHS06,GHS08
• Signal Word: Danger
• Hazard Statements: H301,H361d
• Precautionary Statements: P202 - P264 - P280 - P301 + P310 - P405 - P501
• Hazard Classifications: Acute Tox. 3 Oral - Repr. 2
• Storage Class Code: 6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
• WGK: WGK 3
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable